Daxor Corporation (DXR:NASDAQ) closed at $8.48 on November 13, 2026, up 0.24% on the day. The stock trades 42.5% below its 52-week high of $14.76 and 2.9% above its 52-week low of $8.24. Over the past year, it lost 34.5%. Daxor Corporation is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, DXR closed higher on 103 days (41%). Its best day was September 1, 2026 (+8.13%) and its worst was February 2, 2026 (-8.13%). It never moved 10% or more in a single session.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Find more stocks like DXR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.